We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOP icon
401
Shopify
SHOP
$168B
$4.19M 0.03%
95,082
-16,513
-15% -$727K
GMED icon
402
Globus Medical
GMED
$11.1B
$4.15M 0.03%
79,574
+15,000
+23% +$962K
ZS icon
403
Zscaler
ZS
$24.9B
$4.14M 0.03%
24,610
+3,818
+18% +$458K
TREX icon
404
Trex
TREX
$4.4B
$4.11M 0.03%
91,711
-201,551
-69% -$10.2M
IFF icon
405
International Flavors & Fragrances
IFF
$20.3B
$4.1M 0.03%
48,471
-1,875
-4% -$186K
ALV icon
406
Autoliv
ALV
$9.14B
$4.1M 0.03%
47,739
+35,981
+306% +$3.18M
WBD icon
407
Warner Bros
WBD
$64.3B
$4.09M 0.03%
294,249
-32,836
-10% -$467K
F icon
408
Ford
F
$60.9B
$4M 0.03%
345,001
+41,688
+14% +$522K
HPQ icon
409
HP
HPQ
$26B
$3.98M 0.03%
147,494
-17,299
-10% -$497K
ITT icon
410
ITT
ITT
$17.1B
$3.98M 0.03%
50,155
+10,155
+25% +$893K
MOH icon
411
Molina Healthcare
MOH
$10.4B
$3.96M 0.03%
16,073
+6,009
+60% +$1.73M
PAYX icon
412
Paychex
PAYX
$43.4B
$3.93M 0.03%
37,258
+582
+2% +$66.2K
APO icon
413
Apollo Global Management
APO
$69B
$3.91M 0.03%
+67,230
New +$4.5M
EOG icon
414
EOG Resources
EOG
$77.7B
$3.87M 0.03%
36,667
+5,411
+17% +$656K
BCAB icon
415
BioAtla
BCAB
$5.34M
$3.86M 0.03%
31,308
-4,800
-13% -$865K
HAL icon
416
Halliburton
HAL
$26.1B
$3.84M 0.03%
72,059
-43,879
-38% -$1.63M
CBRE icon
417
CBRE Group
CBRE
$43.3B
$3.83M 0.03%
57,121
-20,482
-26% -$1.67M
NLY icon
418
Annaly Capital Management
NLY
$17.3B
$3.8M 0.03%
216,173
-349,533
-62% -$7.37M
NVO
419
Novo Nordisk
NVO
$228B
$3.8M 0.03%
+10
New +$709
FDMT icon
420
4D Molecular Therapeutics
FDMT
$502M
$3.72M 0.03%
+235,000
New +$4.57M
VRSK icon
421
Verisk Analytics
VRSK
$27.7B
$3.71M 0.03%
21,004
-842
-4% -$152K
VLO icon
422
Valero Energy
VLO
$89.5B
$3.7M 0.03%
28,829
-16,745
-37% -$2.25M
AKAM icon
423
Akamai
AKAM
$15.6B
$3.7M 0.03%
51,344
-15,554
-23% -$1.26M
FORG
424
DELISTED
ForgeRock, Inc.
FORG
$3.7M 0.03%
195,134
-62,398
-24% -$1.27M
AKRO
425
DELISTED
Akero Therapeutics
AKRO
$3.7M 0.03%
105,000
-105,000
-50% -$4.68M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.